Confirmed disability progression as a marker of permanent disability in multiple sclerosis

被引:0
|
作者
Sharmin, S. [1 ]
Malpas, C. [1 ,2 ]
Lechner-Scott, J. [3 ,4 ]
Slee, M. [5 ]
McCombe, P. [6 ,7 ]
Vucic, S. [8 ]
Butler, E. [9 ]
Hodgkinson, S. [10 ]
Barnett, M. [11 ]
Skibina, O. [12 ,13 ]
van der Walt, A. [13 ,14 ]
Buzzard, K. [13 ,14 ]
Shaw, C. [15 ]
Kermode, A. [16 ,17 ,18 ]
Taylor, B. [19 ]
Shuey, N. [20 ]
Macdonell, R. [21 ]
Butzkueven, H. [13 ,14 ]
Kalincik, T. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Dept Neurol, Melbourne MS Ctr, Melbourne, Vic, Australia
[3] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia
[4] Hunter New England Hlth, John Hunter Hosp, Dept Neurol, Newcastle, NSW, Australia
[5] Flinders Univ S Australia, Adelaide, SA, Australia
[6] Univ Queensland, Brisbane, Qld, Australia
[7] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[8] Westmead Hosp, Sydney, NSW, Australia
[9] Monash Med Ctr, Melbourne, Vic, Australia
[10] Liverpool Hosp, Sydney, NSW, Australia
[11] Brain & Mind Ctr, Sydney, NSW, Australia
[12] Monash Univ, Melbourne, Vic, Australia
[13] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia
[14] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[15] Geelong Hosp, Geelong, Vic, Australia
[16] Univ Western Australia, Perron Inst, Nedlands, WA, Australia
[17] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia
[18] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
[19] Royal Hobart Hosp, Hobart, Tas, Australia
[20] St Vincents Hosp, Melbourne, Vic, Australia
[21] Austin Hlth, Melbourne, Vic, Australia
关键词
sustained disability progression; functional system impairment; risk prediction; clinical trial; CLARITY;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:8 / 8
页数:1
相关论文
共 50 条
  • [1] Confirmed disability progression as a marker of permanent disability in multiple sclerosis
    Sharmin, S.
    Malpas, C.
    Lechner-Scott, J.
    Slee, M.
    McCombe, P.
    Vucic, S.
    Butler, E.
    Hodgkinson, S.
    Barnett, M.
    Skibina, O.
    van der Walt, A.
    Buzzard, K.
    Shaw, C.
    Kermode, A.
    Taylor, B.
    Shuey, N.
    Macdonell, R.
    Butzkueven, H.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 8 - 8
  • [2] Confirmed disability progression as a marker of permanent disability in multiple sclerosis
    Sharmin, Sifat
    Bovis, Francesca
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva Kubala
    Izquierdo, Guillermo
    Eichau, Sara
    Trojano, Maria
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Grammond, Pierre
    Sola, Patrizia
    Ferraro, Diana
    Terzi, Murat
    Gerlach, Oliver
    Alroughani, Raed
    Boz, Cavit
    Shaygannejad, Vahid
    van Pesch, Vincent
    Cartechini, Elisabetta
    Kappos, Ludwig
    Lechner-Scott, Jeannette
    Bergamaschi, Roberto
    Turkoglu, Recai
    Solaro, Claudio
    Iuliano, Gerardo
    Granella, Franco
    Van Wijmeersch, Bart
    Spitaleri, Daniele
    Slee, Mark
    McCombe, Pamela
    Prevost, Julie
    Ampapa, Radek
    Ozakbas, Serkan
    Sanchez-Menoyo, Jose Luis
    Soysal, Aysun
    Vucic, Steve
    Petersen, Thor
    de Gans, Koen
    Butler, Ernest
    Hodgkinson, Suzanne
    Sidhom, Youssef
    Gouider, Riadh
    Cristiano, Edgardo
    Castillo-Trivino, Tamara
    Saladino, Maria Laura
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (08) : 2321 - 2334
  • [3] Is the current trial definition of confirmed disability progression in multiple sclerosis an accurate measure of permanent disease progression?
    Butzkueven, H.
    Mechati, S.
    Hoffmann, M.
    Arruda, W. O.
    Bacile, E.
    Boz, C.
    Caride, A.
    Chapman, J.
    Charest, S.
    Cristiano, E.
    Deri, N.
    Duquette, P.
    Fiol, M.
    Flechter, S.
    Ginestal, R.
    Giuliani, G.
    Grammond, P.
    Grand' Maison, F.
    Izquierdo, G.
    Kappos, L.
    Karussis, D.
    Lechner-Scott, J.
    Melcon, M.
    Naegelin, Y.
    Paine, M.
    Petersen, T.
    Poehlau, D.
    Rodriguez Alfici, A.
    Santiago, V.
    Savino, A.
    Timmermans, B.
    Trojano, M.
    Turk Boru, U.
    Ucles, A.
    Verheul, F.
    Jolley, D.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S5 - S5
  • [4] Composite confirmed disability worsening is a useful clinical trial endpoint for multiple sclerosis focusing on a disability progression
    Kappos, Ludwig
    Yiu, Sean
    Cutter, Gary
    Coetzee, Timothy
    Bonati, Ulrike
    Yuen, Steven
    Dahlke, Frank
    Lublin, Fred
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 338 - 339
  • [5] Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis
    Gasperi, C.
    Salmen, A.
    Antony, G.
    Bayas, A.
    Dankowski, T.
    Heesen, C.
    Kmpfel, T.
    Linker, R. A.
    Paul, F.
    Stangel, M.
    Tackenberg, B.
    Bergh, F. Then
    Tumani, H.
    Warnke, C.
    Weber, F.
    Wiendl, H.
    Wildemann, B.
    Zettl, U. K.
    Ziemann, U.
    Zipp, F.
    Gold, R.
    Hemmer, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 301 - 303
  • [6] The VEMP score: a promising marker of disability progression in patients with multiple sclerosis
    Gabelic, T.
    Skoric, M. Krbot
    Adamec, I.
    Habek, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 332 - 332
  • [7] Multiple Sclerosis, disability and progression in Pakistan
    Wasay, M.
    Khatri, I.
    Jabeen, K.
    Ali, S.
    Subhan, M.
    Shahbaz, N.
    Ahmed, A.
    Khoso, N.
    Asif, A.
    Fredrikson, S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S196 - S196
  • [8] Measuring disability progression in multiple sclerosis
    Achiron, Anat
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 6) : 31 - 36
  • [9] Smoking and disability progression in multiple sclerosis
    Hedstrom, Anna Karin
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (08) : 739 - 741
  • [10] Measuring disability progression in multiple sclerosis
    Anat Achiron
    [J]. Journal of Neurology, 2006, 253 : vi31 - vi36